These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 22441722)

  • 1. Hypogonadism secondary to hyperprolactinaemia: successful treatment but adverse consequences.
    Narayanan RP; Bujawansa S; Qureshi Z; Rimmer M; Heald A
    Exp Clin Endocrinol Diabetes; 2012 May; 120(5):311-3. PubMed ID: 22441722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of hypogonadotropic hypogonadism with tamoxifen in a patient with hyperprolactinemia resistant to dopamine agonists.
    López JM; Oestreicher E
    Fertil Steril; 2005 Sep; 84(3):756. PubMed ID: 16169415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment for prolactinomas and hyperprolactinaemia: a lifetime approach.
    Mann WA
    Eur J Clin Invest; 2011 Mar; 41(3):334-42. PubMed ID: 20955213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipsychotic-induced hyperprolactinaemia.
    Inder WJ; Castle D
    Aust N Z J Psychiatry; 2011 Oct; 45(10):830-7. PubMed ID: 21714721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testosterone replacement-induced hyperprolactinaemia: case report and review of the literature.
    Sodi R; Fikri R; Diver M; Ranganath L; Vora J
    Ann Clin Biochem; 2005 Mar; 42(Pt 2):153-9. PubMed ID: 15829128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term treatment of bromocriptine-intolerant prolactinoma patients with CV 205-502.
    Glaser B; Nesher Y; Barziliai S
    J Reprod Med; 1994 Jun; 39(6):449-54. PubMed ID: 7932398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperprolactinaemia in 271 women: up to three decades of clinical follow-up.
    Berinder K; Stackenäs I; Akre O; Hirschberg AL; Hulting AL
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):450-5. PubMed ID: 16181238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperprolactinemia and prolactinomas.
    Mancini T; Casanueva FF; Giustina A
    Endocrinol Metab Clin North Am; 2008 Mar; 37(1):67-99, viii. PubMed ID: 18226731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperprolactinaemia.
    Prabhakar VK; Davis JR
    Best Pract Res Clin Obstet Gynaecol; 2008 Apr; 22(2):341-53. PubMed ID: 17889620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperprolactinaemia and hypogonadism in men: response to exogenous gonadotrophins.
    Luboshitzky R; Rosen E; Trestian S; Spitz IM
    Clin Endocrinol (Oxf); 1979; 11(2):217-23. PubMed ID: 487619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolactin excess: treatment and toxicity.
    Gillam MP; Fideleff H; Boquete HR; Molitch ME
    Pediatr Endocrinol Rev; 2004 Nov; 2 Suppl 1():108-14. PubMed ID: 16456489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prolactin level.
    Piketty ML; Nataf F; Dilouya A; Roux FX
    J Neurosurg; 2000 Feb; 92(2):368-9. PubMed ID: 10659034
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of rheumatoid arthritis with the dopamine agonist quinagolide.
    Eijsbouts A; van den Hoogen F; Laan RF; Hermus RM; Sweep FC; van de Putte L
    J Rheumatol; 1999 Oct; 26(10):2284-5. PubMed ID: 10529161
    [No Abstract]   [Full Text] [Related]  

  • 14. Dopaminergic resistant prolactinomas in the peripubertal population.
    Huang C; Ezzat S; Asa SL; Hamilton J
    J Pediatr Endocrinol Metab; 2006 Jul; 19(7):951-3. PubMed ID: 16995577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for dopamine agonists in the treatment of acromegaly.
    Jaquet P
    J Endocrinol; 1997 Oct; 155 Suppl 1():S59-60. PubMed ID: 9389998
    [No Abstract]   [Full Text] [Related]  

  • 16. Surgery combined with dopamine agonists versus dopamine agonists alone in long-term treatment of macroprolactinoma: a retrospective study.
    Höfle G; Gasser R; Mohsenipour I; Finkenstedt G
    Exp Clin Endocrinol Diabetes; 1998; 106(3):211-6. PubMed ID: 9710362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anejaculation as the presenting feature of pituitary microadenoma.
    Nair S; Milsom S
    Fertil Steril; 2008 Nov; 90(5):2012.e21-3. PubMed ID: 18394608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cabergoline and hyperprolactinaemia: new preparation. Better than bromocriptine.
    Prescrire Int; 2000 Feb; 9(45):195-7. PubMed ID: 11503793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of prolactinoma with a new dopamine agonist].
    Svoboda T; Luger A; Knosp E; Geyer G
    Dtsch Med Wochenschr; 1991 Aug; 116(33):1224-7. PubMed ID: 1678695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of mania after long-term use of quinagolide.
    Vinkers DJ; van der Wee NJ
    Gen Hosp Psychiatry; 2007; 29(5):464. PubMed ID: 17888817
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.